ClinicalTrialsFinder

Non-Hodgkin Lymphoma, Refractory Clinical Trials in New York, New York

1 recruitingNew York, New York

Showing 1–1 of 1 trials

Recruiting
Phase 1

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

Non-Hodgkin Lymphoma, AdultNon-Hodgkin Lymphoma, RefractoryNon-Hodgkin Lymphoma, Relapsed
Marker Therapeutics, Inc.79 enrolled7 locationsNCT05798897